| Inhibition of anti-IgM-stimulated human B cell proliferation assessed as [3H]thymidine incorporation preincubated for 30 mins measured after 3 days - BioAssay Summary Imidazo[1,5-a]quinoxalines were synthesized that function as irreversible Bruton's tyrosine kinase (BTK) inhibitors. The syntheses and SAR of this series of compounds are presented as well as the X-ray crystal structure of the lead compound 36 in complex with a gate-keeper variant of ITK enzyme. The lead compound showed good in vivo efficacy in preclinical RA models. ..more |
_ | |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||
BioActive Compounds: 24 Description: Title: Imidazo[1,5-a]quinoxalines as irreversible BTK inhibitors for the treatment of rheumatoid arthritis. Abstract: Imidazo[1,5-a]quinoxalines were synthesized that function as irreversible Bruton's tyrosine kinase (BTK) inhibitors. The syntheses and SAR of this series of compounds are presented as well as the X-ray crystal structure of the lead compound 36 in complex with a gate-keeper variant of ITK enzyme. The lead compound showed good in vivo efficacy in preclinical RA models. (PMID: 21958547) Comment Compounds with activity <= 50uM or explicitly reported as active by ChEMBL are flagged as active in this PubChem assay presentation. Putative Target: ChEMBL Target ID: 22226 Target Type: UNCHECKED Pref Name: Unchecked Confidence: Default value - Target unknown or has yet to be assigned Relationship Type: Default value - Target has yet to be curated Categorized Comment ChEMBL Assay Type: Functional ChEMBL Assay Data Source: Scientific Literature Result Definitions
* Activity Concentration. Data Table (Concise)
PageFrom: |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||